About us

The story

EarlySight is a Swiss startup company based in Geneva that aims at revolutionizing care of diseases affecting the eye. The company was founded in 2019 as a spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL). The co-founders are two engineers: Timothé Laforest, PhD and Mathieu Kunzi, and two professors: Francine Behar-Cohen, MD, PhD and Christophe Moser, PhD. They have developed an imaging tool able to see the eye fundus at microscopic level and measure its biological structure. Coupled to an AI software, the tool has the potential to precisely detect and monitor disease biomarkers.

Timothé LAFOREST

CEO & Co-founder

“EarlySight was born with a vision – to radically improve patient care by giving doctors the tool for earlier detection and better monitoring of retinal diseases.
With the unique ability to observe the retina down to the cellular level, EarlySight technology is at the forefront of imaging devices. The development of its AI-driven digital biomarker software will enable the company to offer a complete solution for eye doctors. It is the right time to answer the need for precision medicine.
I am proud to lead the EarlySight journey with the commitment of our collaborators, support from our investors, and the trust of our partners.”

Vision

Our mission is to reduce vision loss and enhance patients’ quality of life by radically improving management of eye diseases. We believe that precise eye imaging and analysis will enable improved diagnosis, monitoring and treatment for millions of people.

Innovation

Our technology stems from years of research at the Swiss Federal Institute of Technology in Lausanne (EPFL).

Quality

Our products are designed, developed, and manufactured in Switzerland, known for its reliable and precise industry.

Passion

We are a team of passionate individuals committed to advancing ophthalmic care.

Strengths and key figures

We’ve been working for several years with large hospitals in Switzerland. They’ve already used prototypes of our technology on more than 300 patients within clinical research projects with impressive results. The feedbacks obtained from our end users allow us to continuously improve the design of our future products to better answer their needs. The company is ISO 13485 certified for its quality management system. Compliance with this standard ensures efficient processes and an organized structure of the company to provide high-quality products tailored for medical professionals.

Patients examined

Countries with business partners

Patents

Our team

The greatest value of a company is the people composing it. EarlySight is pleased to have a passionate and highly skilled international team along with eminent medical advisors, expert in the field of ophthalmology.

Team

Board of Directors

Scientific Council

Team